Breaking News Instant updates and real-time market news.

LXRX

Lexicon

$2.08

0.66 (46.48%)

, SNY

Sanofi

$43.54

0.57 (1.33%)

08:13
09/11/19
09/11
08:13
09/11/19
08:13

Lexicon upgraded to Buy at Gabelli, says agreement a 'clean break'

Gabelli analyst Kevin Kedra upgraded Lexicon to Buy from Hold after the company said Sanofi (SNY) has finalized its termination of the sotagliflozin collaboration with a $260M payment, citing valuation and increased optimism for sotagliflozin's future. In a research note to investors, Kedra says the agreement is a "clean break" from Sanofi while also modestly extending Lexicon's cash runway, and expects Lexicon to have enough cash to support operations into 2021.

LXRX

Lexicon

$2.08

0.66 (46.48%)

SNY

Sanofi

$43.54

0.57 (1.33%)

  • 16

    Sep

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

LXRX Lexicon
$2.08

0.66 (46.48%)

07/30/19
SBSH
07/30/19
NO CHANGE
Target $3
SBSH
Buy
Citi cuts Lexicon target to $3 from $15, still sees value in sotagliflozin
Citi analyst Yigal Nochomovitz lowered his price target for Lexicon Pharmaceuticals (LXRX) to $3 from $15 while keeping a Buy rating on the shares. The analyst believes Sanofi's (SNY) decision to terminate the partnership reflects to a greater extent Sanofi's prioritization of the internal pipeline and renewed focus on core areas versus specific liabilities regarding sotagliflozin. He still sees see some value in sotagliflozin and thinks shares of Lexicon are worth $3, well above yesterday's closing price of $1.69.
08/01/19
WEDB
08/01/19
NO CHANGE
Target $17
WEDB
Outperform
Lexicon price target lowered to $17 from $35 at Wedbush
Wedbush analyst Liana Moussatos lowered her price target for Lexicon (LXRX) to $17 from $35 to reflect a reduction in Zynquist sales projections. On July 26, partner Sanofi (SNY) announced the intent to terminate the diabetes partnership for Zynquista, which Lexicon indicated was due to not achieving statistical significance for the primary endpoint of reducing placebo-adjusted HbA1c in T2D patients with stage 3b/4 CKD, she contends, adding that Lexicon commented that there were strong trends favoring Zynquista in these patients and is disputing the termination. Moussatos reiterates an Outperform rating on Lexicon's shares.
09/11/19
SBSH
09/11/19
NO CHANGE
Target $3
SBSH
Buy
Lexicon settlement with Sanofi removes overhang, says Citi
Citi analyst Yigal Nochomovitz believes Lexicon Pharmaceuticals' (LXRX) settlement with Sanofi (SNY) removes an overhang and that the company's cash runway "may increase modestly." However, the funds are largely already spoken for with respect to continued funding of the core Phase 3 trials in n type 2 diabetes and the outcomes trials, Nochomovitz tells investors in a research note. The analyst keeps a Buy rating on Lexicon shares with a $3 price target.
09/11/19
GABE
09/11/19
UPGRADE
GABE
Buy
Lexicon upgraded to Buy from Hold at Gabelli
SNY Sanofi
$43.54

0.57 (1.33%)

08/14/19
08/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Evercore Partners (EVR) upgraded to Neutral from Sell at Goldman Sachs with analyst Richard Ramsden saying believes that stronger U.S. large cap deal activity than he previously expected should support Evercore's revenues. 2. Sanofi (SNY) upgraded to Buy from Neutral at UBS with analyst Laura Sutcliffe saying she sees signs of a turnaround for the company and believes its pipeline can fixed ahead of patent expiration. 3. Bristol-Myers (BMY) upgraded to Overweight from Neutral at Atlantic Equities. 4. Horizon Pharma (HZNP) upgraded to Outperform from Market Perform at BMO Capital with analyst Gary Nachman citing the company's "strong" Q2 results driven by Krystexxa. 5. Ferrari (RACE) upgraded to Buy from Neutral at Goldman Sachs with analyst George Galliers citing the company's Q2 results earlier this month. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/03/19
BERN
09/03/19
INITIATION
Target $52
BERN
Outperform
Sanofi initiated with an Outperform at Bernstein
Bernstein analyst Wimal Kapadia initiated Sanofi with an Outperform and $52 price target.
09/03/19
09/03/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Wayfair (W) initiated with a Buy at Goldman Sachs. 2. Square (SQ) initiated with an Underweight at Atlantic Equities. 3. InMode (INMD) initiated with an Outperform at Baird, an Overweight at Barclays, and a Buy at Canaccord and UBS. 4. Sanofi (SNY) initiated with an Outperform at Bernstein. 5. RealReal (REAL) initiated with an Outperform at Wells Fargo. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
09/23/19
09/23
13:17
09/23/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
09/23/19
09/23
13:16
09/23/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
09/23/19
09/23
13:15
09/23/19
13:15
General news
Fed's Bullard said the Committee might opt to ease again »

Fed's Bullard said…

NVO

Novo Nordisk

$53.06

0.11 (0.21%)

13:05
09/23/19
09/23
13:05
09/23/19
13:05
Options
Novo Nordisk call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

IPHI

Inphi

$60.80

-2.69 (-4.24%)

, AMZN

Amazon.com

$1,789.48

-4.16 (-0.23%)

12:59
09/23/19
09/23
12:59
09/23/19
12:59
Recommendations
Inphi drops after Northland sees 'large cut' to Amazon 400G rollout plans »

Northland analyst Tim…

IPHI

Inphi

$60.80

-2.69 (-4.24%)

AMZN

Amazon.com

$1,789.48

-4.16 (-0.23%)

CSCO

Cisco

$49.59

(0.00%)

ACIA

Acacia Communications

$64.58

-0.04 (-0.06%)

LITE

Lumentum

$57.55

-1.28 (-2.18%)

NPTN

NeoPhotonics

$6.24

-0.03 (-0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 26

    Sep

  • 10

    Oct

  • 27

    Oct

  • 13

    Nov

HUYA

Huya

$27.43

-0.47 (-1.68%)

12:55
09/23/19
09/23
12:55
09/23/19
12:55
Options
HUYA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLY

Annaly Capital

$9.02

0.06 (0.67%)

12:45
09/23/19
09/23
12:45
09/23/19
12:45
Options
Annaly Capital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRT

Trio-Tech

$3.79

0.08 (2.16%)

12:45
09/23/19
09/23
12:45
09/23/19
12:45
Hot Stocks
Breaking Hot Stocks news story on Trio-Tech »

Trio Tech International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
09/23/19
09/23
12:45
09/23/19
12:45
General news
Breaking General news story  »

St. Louis Federal Reserve…

IPHI

Inphi

$61.21

-2.28 (-3.59%)

12:43
09/23/19
09/23
12:43
09/23/19
12:43
Recommendations
Inphi analyst commentary  »

Inphi mentioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRT

Trio-Tech

$3.79

0.08 (2.16%)

12:41
09/23/19
09/23
12:41
09/23/19
12:41
Earnings
Trio-Tech reports Q4 EPS 12c vs. 17c last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$377.77

-1.56 (-0.41%)

, ERJ

Embraer

$18.27

-0.46 (-2.46%)

12:37
09/23/19
09/23
12:37
09/23/19
12:37
Periodicals
Boeing bid of Embraer unit faces EU antitrust probe, Reuters reports »

The European Union's…

BA

Boeing

$377.77

-1.56 (-0.41%)

ERJ

Embraer

$18.27

-0.46 (-2.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

OBAS

Optibase

$12.50

(0.00%)

12:36
09/23/19
09/23
12:36
09/23/19
12:36
Hot Stocks
Optibase: Appeal filed against court decision to deny motion to approve claim »

Optibase announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$114.56

-1.6 (-1.38%)

12:35
09/23/19
09/23
12:35
09/23/19
12:35
Options
Eli Lilly put volume heavy and directionally bearish »

Bearish flow noted in Eli…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 23

    Oct

AEM

Agnico Eagle

$59.23

1.02 (1.75%)

12:32
09/23/19
09/23
12:32
09/23/19
12:32
Conference/Events
Agnico Eagle management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 24

    Oct

TRT

Trio-Tech

$3.79

0.08 (2.16%)

12:26
09/23/19
09/23
12:26
09/23/19
12:26
Hot Stocks
Breaking Hot Stocks news story on Trio-Tech »

Trio Tech International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDE

Coeur Mining

$5.65

0.38 (7.21%)

12:25
09/23/19
09/23
12:25
09/23/19
12:25
Options
Coeur Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:20
09/23/19
09/23
12:20
09/23/19
12:20
General news
A Firming Pattern for U.S. Producer Sentiment: »

A Firming Pattern for…

PSTV

Plus Therapeutics

$11.00

3.04 (38.19%)

12:17
09/23/19
09/23
12:17
09/23/19
12:17
Syndicate
Plus Therapeutics 3M unit offering priced at $5 per unit »

Plus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
09/23/19
09/23
12:17
09/23/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
09/23/19
09/23
12:16
09/23/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYSI

BeyondSpring

$18.78

0.92 (5.15%)

12:15
09/23/19
09/23
12:15
09/23/19
12:15
Hot Stocks
BeyondSpring to present Pegfilgrastim data at ESMO Congress »

BeyondSpring announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

AZO

AutoZone

$1,160.25

-0.13 (-0.01%)

, KMX

CarMax

$86.63

1.95 (2.30%)

12:15
09/23/19
09/23
12:15
09/23/19
12:15
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

AZO

AutoZone

$1,160.25

-0.13 (-0.01%)

KMX

CarMax

$86.63

1.95 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 24

    Sep

  • 28

    Sep

AA

Alcoa

$21.36

-0.34 (-1.57%)

12:15
09/23/19
09/23
12:15
09/23/19
12:15
Options
Alcoa put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

AVY

Avery Dennison

$113.78

0.95 (0.84%)

12:12
09/23/19
09/23
12:12
09/23/19
12:12
Recommendations
Avery Dennison analyst commentary  »

Avery Dennison continues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.